Articles tagged with "Immunology"

Sort by

PacBio system to assist Estonia’s national genome scheme

April 1, 2024
Estonia’s University of Tartu has chosen PacBio’s Revio HiFi sequencing system for the next stage of one of the most ambitious national population genome projects.

UK’s status as global clinical trials hub bolstered with £18 million investment

March 24, 2024
The National Institute for Health and Care Research (NIHR), Innovate UK, the Advanced Therapy Treatment Centre Network and the Cell and Gene Therapy Catapult (CGT Catapult) have announced a strategic...

‘Potash price rise undermines global food security’ warning

February 25, 2024
Rising prices for potash across the globe are creating a threat to the level of global food security warns a new joint study by UCL, the University of Edinburgh and...

Anglo-Norwegian study casts light on treatment resistant bacteria

February 4, 2024
A study comparing the UK and Norway over two decades, has concluded that antibiotic use may drive a rise in treatment-resistant bacteria but not in every instance.

Modern microscopy identifies Dutch master’s £175k handiwork

December 21, 2023
A microscope discovered by chance in a house clearance has been authenticated as the work of ‘the father of microbiology’, the 17th century scientist Antony van Leeuwenhoek.

Azenta’s Oxford genomics lab to open in March

December 21, 2023
Azenta Life Sciences has selected Oxford as the location for its state of the art genomics lab opening in early 2024.

Therapy ‘alters immune cells’ to fight unresponsive tumours

December 10, 2023
Finnish researchers say they have discovered how a new cancer therapy can alter the function of immune cells to enable them to infiltrate tumours previously unresponsive to treatment.

DEFRA data share essential to pandemic preparation urges expert

November 27, 2023
Non-healthcare bodies such as DEFRA need to collaborate more fully with healthcare organisations in order to boost preparations against new pandemics, warned a leading genomics expert.

Newly launched firm secures £4.3 million seed funding to target drug-resistant bacteria

November 19, 2023
Glox Therapeutics, a company developing precision antibiotic therapies, has raised £4.3 million in seed funding to develop effective targeted therapeutics against antibiotic-resistant bacteria.

Pin It on Pinterest